A genetic predisposition is observed in about 5–10% of breast cancers, and BRCA1 and BRCA2 are the most recognized mutations associated with a lifetime risk for breast cancer of 50–85% and 45–69%, respectively [12]. This evidence concerns the gene BRCA2 and breast cancer.